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Cell Biology/Signaling
Characterization of Ion Channels Involved in the
Proliferative Response of Femoral Artery Smooth
Muscle Cells
Pilar Cidad, Alejandro Moreno-Domínguez, Laura Novensa´, Merce´ Roque´, Leire Barquín,
Magda Heras, M. Teresa Pe´rez-García, Jose´ R. Lo´pez-Lo´pez
Objective—Vascular smooth muscle cells (VSMCs) contribute significantly to occlusive vascular diseases by virtue of their
ability to switch to a noncontractile, migratory, and proliferating phenotype. Although the participation of ion channels
in this phenotypic modulation (PM) has been described previously, changes in their expression are poorly defined
because of their large molecular diversity. We obtained a global portrait of ion channel expression in contractile versus
proliferating mouse femoral artery VSMCs, and explored the functional contribution to the PM of the most relevant
changes that we observed.
Methods and Results—High-throughput real-time polymerase chain reaction of 87 ion channel genes was performed
in 2 experimental paradigms: an in vivo model of endoluminal lesion and an in vitro model of cultured VSMCs
obtained from explants. mRNA expression changes showed a good correlation between the 2 proliferative models,
with only 2 genes, Kv1.3 and Kv2, increasing their expression on proliferation. The functional characterization
demonstrates that Kv1.3 currents increased in proliferating VSMC and that their selective blockade inhibits
migration and proliferation.
Conclusion—These findings establish the involvement of Kv1.3 channels in the PM of VSMCs, providing a new
therapeutical target for the treatment of intimal hyperplasia. (Arterioscler Thromb Vasc Biol. 2010;30:1203-1211.)
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 vascular remodeling
Vascular smooth muscle cells (VSMCs) are differenti-ated cells that regulate vessel diameter and determine
tissue perfusion. However, they can exhibit a variety of
functionally dissimilar phenotypes. In response to local
cues, VSMCs experience a phenotypic modulation (PM),
with profound and reversible changes leading to prolifer-
ation, migration, and secretion of extracellular matrix
components.1 This plasticity is essential for injury repair,
but it also contributes to the development and progression
of vascular disease in response to abnormal environmental
signals. It is becoming evident that contractile and prolif-
erative phenotypes represent extreme cases of a spectrum
of phenotypes that may coexist as the result of a develop-
mentally regulated genetic program constantly modulated
by environmental cues. This explains both a relatively
stable expression of certain transcriptional programs in
different VSMCs and a marked plasticity of these cells,
including the ability to respond with different genetic
programs to readjust cellular activity to mechanical and
hormonal factors.1–3
See accompanying article on page 1073
The switch in ion transport mechanisms associated with
PM is getting increasing amounts of attention. Coordinate
changes in ion channels are an integral component of
VSMC plasticity, as they can redirect biochemical activity
toward new functional responses.4,5 Moreover, both con-
tractile and proliferative signals require specific changes in
intracellular [Ca2] and membrane potential that are de-
termined by the ion channels expressed in VSMCs. Re-
modeling of several ion channels has shown to be func-
tionally important for the PM of VSMCs in several
preparations.5–10 These data contribute to our understand-
ing of VSMC modulation, but also, importantly, they can
provide new targets for the treatment of vascular disorders.
To date, studies of ion channel distribution within specific
vascular beds and the modifications of ion channels on
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remodeling have been limited to a small number of
candidate subunits believed to be of importance. In addi-
tion, the complexity of their characterization in the in vivo
models has led most investigators to extrapolate from the
data obtained from cultured VSMCs as a proliferative
phenotype, because VSMCs in intimal hyperplasic lesions
resemble dedifferentiated myofibroblasts or cultured
VSMCs. However, the emerging picture regarding the
phenotypic regulation of VSMCs shows a large degree of
diversity, reflecting both intrinsic variability of VSMCs
among vascular beds and the specific responses to the
different proliferative signals present in cultured cells and
in the in vivo lesions.
Here, we used a quantitative approach to obtain a global
portrait of ion channel gene expression in contractile VSMCs
from mouse femoral arteries and their changes on PM in 2
proliferative models: an in vivo model of neointimal
hyperplasia induced by endoluminal lesion11 and an in
vitro model using cultured VSMCs from arterial explants.
Two genes (Kv1.3 and Kv2) showed a concordant up-
regulation in both models, and the expression and function
of Kv1.3 proteins was explored. Electrophysiological stud-
ies in cultured VSMCs and VSMCs from injured arteries
show an increased functional expression of Kv1.3 currents.
Pharmacological or genetic Kv1.3 blockade inhibits cul-
tured VSMC migration and proliferation, and this inhibi-
tion cannot be mimicked by VSMC depolarization. Fi-
nally, the analysis of other vascular beds confirms that
upregulation of Kv1.3 associates with PM, suggesting that
they can represent a good therapeutical target by which to
control VSMC proliferation.
Materials and Methods
An expanded Materials and Methods section is given in the supple-
mental material, available online at http://atvb.ahajournals.org.
Animals
Blood pressure normal (BPN) mice (The Jackson Laboratory) were
maintained with inbred crossing in the animal facilities of the schools
of medicine of the universities of Valladolid and Barcelona. Unilat-
eral transluminal injury of femoral arteries was performed by
passage of a 0.25-mm-diameter angioplasty guide wire, as previously
described.11
VSMC Isolation
Mice were killed by decapitation after isofluorane anesthesia. Fem-
oral arteries were dissected and cleaned of connective and endothe-
lial tissues, and they were stored for RNA extraction or used directly
to obtain fresh dispersed VSMCs or cultured VSMCs as previously
described.8,12
RNA Expression Profile
TaqMan low-density arrays (Applied Biosystems) were used to
simultaneously quantify the expression of 96 genes per sample.12
Each sample derived from 500 ng of mRNA from contractile or
proliferating VSMCs.
Protein Expression and Function
Selective antibodies were used for protein detection with immuno-
logic methods.8,11 The whole-cell and perforated-patch configura-
tions of the patch-clamp technique were used for functional studies
in isolated VSMCs8,12
Migration and Proliferation Studies
Migration of cultured VSMCs was studied by a scratch assay and
proliferation was determined by 5-bromo-2-deoxyuridine (BrdU)
incorporation.
Results
Expression Profile of Ion Channel Genes in
Femoral VSMCs
The transcriptional expression levels of 87 ion channel
subunits in VSMCs from mouse femoral arteries were
investigated by real-time polymerase chain reaction. These
channel genes include , , and  subunits of K channels
and  subunits of voltage-dependent Ca2 channels, Cl
channels, and Trp channels. The expression levels of
markers of VSMCs (calponin, Cnn1) and endothelium
(endothelial nitric oxide synthase, Nos3, and von Wille-
brand factor), were also explored, as well as other endog-
enous controls (Gapdh, B2m, Hprt-1, and Klf5). Expres-
sion of 26 channel genes was undetectable after 40 cycles
of amplification under all conditions.
The relative abundance of the 54 channel genes found in
the control preparation (mRNA from intact femoral arter-
ies, with endothelium, CE) is shown in Figure 1. Genes
are grouped by families, and their expression levels are
normalized to the endogenous control ribosomal protein
18S. We detected expression of 1 Cl channel (Clcn3) and
several inward rectifier and 2-pore domain K channels.
We found expression of all members of the Ca2-
dependent K channels (KCa) family, with the exception of
the maxiK (BKCa)  subunit BK2; of them, the BK and
BK1 subunits were among the most abundantly expressed
channel genes. Within the voltage-dependent K channels
(Kv channels), we found expression of several accessory
subunits, as well as pore-forming  subunits of members
of the Kv1 to Kv4 and Kv11 subfamilies. Voltage-
dependent Ca2 channels are represented by Cav1 and
Cav3 subfamily members. Finally, we detected expression
of a large number of Trp channels of the Trpc, Trpv, Trpm,
and Trpp subfamilies, with Trpp2 being the most abundant
transcript.
Changes in the expression profile of ion channels
induced by the switch to a proliferative phenotype were
studied in VSMCs obtained from explants of endothelium-
denuded femoral arteries and kept in culture (in vitro
model) and in endoluminal lesion-induced intimal hyper-
plasia (in vivo model), in which expression changes were
studied at 3 different times after lesion (48 hours, 1 week,
and 4 weeks). Each model had its own control: endo-
thelium-free arteries (CE) for the in vitro model and
endothelium intact arteries (CE) for the in vivo model.
Differences between these 2 controls are summarized in the inset
in Figure 1, where genes whose expression was modified in the
CE samples (relative to CE) are shown.
Changes in proliferation were analyzed by 2 methods.
First, we studied, for each individual gene, the differences
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between control and proliferation in the 2 models by using
the 2Ct relative quantification method13 (Supplemental
Figure III). Second, a 2-way hierarchical clustering anal-
ysis of genes and different experimental conditions14 was
performed and visualized with the Treeview software
(Figure 2). This analysis categorized genes according to
their responses to PM into upregulated and downregulated
genes and also demonstrated time-course–related subclas-
sifications in the model of endoluminal lesion (Figure 2A).
Groups of genes with similarity in the pattern of expres-
sion (indicated by the correlation coefficient) are high-
lighted in Figure 2. Within downregulated genes, we
identified clusters of genes with late decrease expression
(Figure 2, box A), early decrease followed by a partial
recovery (box B), or time-independent decrease (box C).
Similarly, PM-upregulated genes can show a late increase
Figure 1. Relative abundance of the ion channel
genes studied in complete femoral arteries (CE)
expressed as 2Ct, where CtCtchannelCt18s.
Each bar is the meanSEM of 10 determinations
obtained in 5 duplicate assays. Genes are grouped
by families (see online supplemental data for the
list of channel genes). The inset shows fold
changes in expression in endothelium-free arteries
(CE) expressed as log (2
Ct), where
CtCt(CE)Ct(CE). In all figures, *P0.05,
**P0.01, and ***P0.001.
Cidad et al Ion Channels and VSMC Proliferation 1205
 by guest on January 26, 2012http://atvb.ahajournals.org/Downloaded from 
(box D), an early increase with partial recovery (box E), or
a sustained increase (box F). Following these criteria, the
hierarchical clustering of the genes whose expression was
modified in cultured VSMC (Figure 2B) also identified 2
groups of genes with decreased (boxes A through C) or
increased (boxes D through F) expression with
proliferation.
To discern whether these expression patterns were
simply arbitrary structures or rather reflect biologically
significant associations, we performed a statistical analysis
of the data with the GEPAS suite (http://gepas.bioinfo.
cipf.es/), with false discovery rate (FDR) correction.15 We
obtained a significant variation in the expression of 22
genes in the in vivo model and 29 genes in the in vitro
model (Figure 2C). The endoluminal lesion induced a
significant increase in 3 genes (ClCa1, Kv1.3, and Kv2),
and a significant decrease in 19 genes. In cultured VSMCs,
7 genes were overexpressed and 22 exhibited significant
decrease. The overlapping region in Figure 2C shows the
genes with significant changes in their expression profile
common to both proliferative models (18 genes). Of them,
we focused on those with increased expression (Kv1.3 and
Kv2), as they are more amenable to represent therapeu-
tical targets. We studied the presence, distribution, and
Figure 2. A, Two-way hierarchical agglomerative clustering applied to 59 genes (horizontally) and to 5 contractile VSMCs samples
(C1 to C5), 2 samples at 48 hours after endoluminal lesion, 2 samples after 1 week, and 3 samples after 4 weeks (vertically). The
input data were the Ct values for the genes. Color patch represents the expression level for each gene and sample. Expression
levels were normalized within each sample, with a scale ranging from bright green (lowest) to bright red (highest). Missing values
are shown as gray patches. The length of the tree branches is proportional to the correlation of the gene expression pattern, and
some of these clusters and correlation coefficients are indicated. B, Same representation as in A, but comparing the contractile
VSMCs (labeled here as tissues T1 to T3) with the cultured VSMCs (C1 to C3). C, Diagram showing genes exhibiting significant
expression changes (upregulation, red font or downregulation, green font) in endoluminal lesion samples and in cultured VSMCs,
when analyzed with the T-REX set of tools of the GEPAS suite (see Supplemental Methods). The light gray intersection contains
the genes showing the same significant changes in both models.
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functional contribution of Kv1.3 in both proliferative
models.
Functional Expression of Kv Channels in
Femoral VSMCs
Outward K currents were studied with the whole-cell
patch clamp technique in freshly dissociated VSMCs and
in cultured VSMCs from femoral arteries. Figure 3A
shows representative traces obtained in each condition.
Both total outward K current density, and the Kv com-
ponent of this current (ie, the 500 nmol/L paxilline-resis-
tant current16) was significantly larger at all voltages in
VSMCs in the contractile phenotype, but there were no
significant differences in the proportion of the two com-
ponents. However, the Kv1 fraction of the current (the
5 mol/L correolide-sensitive current) was significantly
larger in cultured VSMCs (from 44.121.6% in tissue to
68.696.5% in culture, Figure 3B). The increased func-
tional contribution of Kv1.3 channels can account for this
change, as revealed by selective Kv1.3 blockers (marga-
toxin and PAP-117,18). Current sensitive to 10 nmol/L
margatoxin represented 58.154.54% of the Kv current in
cultured VSMCs versus 10.662.03% in freshly dispersed
VSMCs. Similar results were obtained with 10 nmol/L
PAP-1. The functional contribution of these channels to set
resting VM was explored with the same blockers, providing
parallel results (Figure 3B, bottom). Figure 3C depicts
examples of the pharmacological dissection of the outward
K currents. In the presence of paxilline (500 nmol/L),
application of margatoxin or PAP-1 (10 nmol/L each)
allowed quantification of the Kv1.3 component. After
Kv1.3 blockade, correolide (5 mol/L) was used to selec-
Figure 3. A, Family of current traces obtained in freshly dissociated and cultured VSMCs with the indicated pulse protocol. Cur-
rent density of the total outward K current was calculated in depolarizing pulses to 40 mV. Kv current density was obtained
after BKCa block with 500 nmol/L paxilline. MeanSEM of 14 to 18 cells. B, The upper plot shows the fraction of the total Kv cur-
rent represented by Kv1.x currents (correolide-sensitive) and Kv1.3 currents (margatoxin- or PAP1-sensitive) in contractile (tissue)
versus cultured VSMCs. The amplitude of the depolarization induced by these blockers in perforated-patch recordings is repre-
sented in the lower plot. MeanSEM of 11 to 14 cells. C, Pharmacological characterization of outward K currents in contractile
and cultured VSMCs. Shown are current/voltage relationships obtained in 2 cells in control conditions and after sequential appli-
cation of paxilline (500 nmol/L), margatoxin (10 nmol/L), correolide (5 mol/L), and TEA (20 mmol/L). The Kv1.3 component is rep-
resented by the shaded areas. The traces show current at 80 mV in both cells with each blocker, and pie charts represent the
proportion of Kv1-Kv4 currents in both preparations.
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tively block the remaining Kv1 currents. Subsequent
application of tetraethylammonium chloride (TEA)
(20 mmol/L) identified the amplitude of the Kv2Kv3
component. The minimal residual current, which was
insensitive to correolide and TEA, could reflect Kv4
current component. The molecular composition of Kv
currents in each preparation is illustrated in the pie charts.
In addition to the increased proportion of Kv1 currents,
cultured VSMCs also showed a significant decrease in the
Kv2 (from 36.522.97% to 21.343.71%) and Kv3 (from
16.42.74% to 5.560.97%) components. The Kv3 com-
ponent was estimated as the fraction of the currents
blocked by 100 mol/L TEA after correolide, and the Kv2
component was calculated as the difference between
20 mmol/L and 100 mol/L TEA-sensitive currents.
Kv1.3 Protein Expression in Femoral VSMCs
Changes in Kv1.3 protein expression were explored by
immunocytochemistry in freshly dispersed and cultured
VSMCs and by immunohistochemical labeling in sections
of control and injured femoral arteries. We have also
studied Kv1.5 protein expression as one example of
channel downregulated on PM. Kv1.3 labeling increased in
cultured VSMCs when compared with freshly dispersed
cells, whereas Kv1.5 labeling disappeared (Figure 4A).
Figure 4B shows similar results in sections of femoral
arteries: Kv1.3 staining was weak in control sections, and
increased after lesion (mainly in the intimal layer),
Figure 4. A, Immunocytochemical identification of Kv1.3 and
Kv1.5 protein in freshly dispersed and cultured femoral
VSMCs. Anti-Kv1.3 or anti-Kv1.5 labeling (green) is combined
with 4,6-diamidino-2-phenylindole staining (blue) B, Paraffin
sections of control and injured femoral arteries were labeled
with the indicated antibodies and counterstained with hema-
toxylin. Arrows indicate internal elastic lamina (IEL). C, Sum-
mary data represent the percentage of labeled area over the
total vessel area. MeanSEM of 10 to 25 sections from 6 to
13 animals.
Figure 5. A, Representative example of the changes in peak
current amplitude at 40 mV in a VSMC isolated from an
injured artery with the indicated drugs. B, Labeling with anti-
SM22 (green) demonstrates the vascular smooth muscle lin-
eage of these cells. C, Absolute magnitude of the
margatoxin-sensitive component (IKv1.3) in control (contractile)
and in cultured and injured VSMCs. MeanSEM of 11 to 15
cells.
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whereas labeling with anti-Kv1.5 antibody was detected in
the muscular layer of almost half of the cells in control
arteries, decreasing on injury. Functional characterization
of Kv1.3 currents from VSMCs obtained from injured
arteries (Figure 5A) showed an augmented expression of
the Kv1 component (85.24.5% of the Kv current) due to
an increase of the MgTx-sensitive component
(61.55.2%), very similar to the case with cultured
VSMCs (see Figure 3B). Moreover, increased Kv1.3
current was not simply reflecting downregulation of other
Kv channels, as Kv1.3 current density increased in both
proliferation models (Figure 5C).
Effects of Kv1.3 Blockade on VSMC Migration
and Proliferation
The upregulated functional expression of Kv1.3 could
reflect a link between the channel and the establishment
and maintenance of the proliferative phenotype. To ex-
plore this, we studied the effect of Kv1.3 current blockade
on the ability of cultured VSMCs to migrate and prolifer-
ate. Migration was determined in confluent femoral
VSMCs by a scratch migration assay. After 24 hours in
serum-free medium alone (control) or with 10 nmol/L
PAP-1 or 10 nmol/L margatoxin, the invaded area was
significantly larger in control cells than in cells treated
with the Kv1.3 blockers (Figure 6A). Similarly, the pro-
liferation rate, determined by the number of BrdU cells,
was significantly decreased by Kv1.3 channels blockade
(Figure 6B through 6D). The effect of PAP-1 inhibiting
proliferation was dose dependent (Figure 6B) and could
be mimicked by selective knockdown of Kv1.3 currents
with short interfering RNA (Figure 6C). PAP-1 and mar-
gatoxin depolarized VSMCs, but other maneuvers that also
depolarized cultured VSMCs, such as increasing [K]e or
blockade of Kv2 or BKCa channels, did not affect prolif-
eration (Figure 6D). Moreover, proliferation inhibition by
10 nmol/L margatoxin was attenuated but still significant
in the presence of 20 mmol/L Ke (Figure 6D, inset).
Discussion
This work provides a comprehensive study of the expres-
sion pattern of ion channels in VSMCs, using a quantita-
tive high-throughput technique, with the goal of elucidat-
ing PM-associated changes. We defined the relative
expression of the ion channel genes studied and compared
this profile among different vascular beds, observing a
continuous pattern that correlates with the size of the
arteries (see Supplemental Figure IV), in agreement with
previous data focused on individual channels.19 –23 Charac-
terization of the changes in expression pattern associated
with proliferation in in vivo and in vitro models of PM
Figure 6. A, Effect of Kv1.3 blockers on femoral VSMC migration calculated as the percentage of invaded area in scratch assays.
Images show a representative experiment with 10 nmol/L PAP-1. B, Dose-response effect of PAP-1 on the proliferation rate of
cultured femoral VSMCs measured with a BrdU incorporation assay. n3 to 8 experiments in each group; SF indicates serum-
free medium. C, Two different Kv1.3 short interfering RNAs (siRNAs) were able to reduce mRNA expression (normalized to Gapdh)
and BrdU incorporation in transfected VSMCs compared with mock-transfected or siRNA C – transfected VSMCs (n4). D,
Effects of K channel blockers or high [K]e on resting VM (current-clamp experiments) and on proliferation inhibition (BrdUrd incor-
poration). MeanSEM of 8 to 20 determinations. The inset shows the antiproliferative effect of MgTx (10 nmol/L) in control
medium and in 20 mmol/L K-containing medium. n7 experiments.
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showed a good correlation between both situations. Eigh-
teen of 22 genes that changed in the in vivo model were
conserved in cultured VSMCs. The larger number of genes
that changed in cultured VSMCs can be attributed to their
more homogeneous nature (a uniform population of syn-
thetic VSMCs), whereas endoluminal lesion samples are
partially contaminated with endothelial cells, contractile
VSMCs, and connective tissue. These contaminants could
also explain some of the changes present only in this
model, as it is most likely the case of SK3 channels (small
conductance KCa channels), whose expression is restricted
to endothelial cells.9,24 Although specific changes induced
by the culture conditions cannot be excluded, our analysis
indicates that ion channel expression profile in cultured
VSMCs reproduces reasonably well the changes in prolif-
erating lesions in vivo. This observation is important
considering the technical limitations of the in vivo models
for functional studies.
Only some of the channels highlighted here have been
previously reported as relevant to VSMC proliferation.
Downregulation of several Kv1 genes (Kv1.5, Kv1.2, and
Kv2.1) has been reported in other preparations.8,25 Also,
decreased expression of Cav1.2 mRNA is consistent with
the reported reduction in the functional expression of
L-type Ca2 channels in synthetic VSMCs,5,26 although we
did not detect the concomitant upregulation of genes of the
Trpc and Cav3.x families described in these studies.
Similarly, decreases of the BK channel genes (BK and
BK1 subunits) have been described,5,8,9,27 but we did not
find the associated increase in IK1 mRNA that was
previously reported.5,9,10 Nevertheless, a contribution to
PM in our preparation of these channels (Trpc, Cav3.x, or
IK1) via posttranscriptional modulation cannot be ex-
cluded. Overall, vascular bed variations may account for
some of the recounted discrepancies, and it is tempting to
speculate that not only the expression profile of ion
channels but also the PM-induced changes could be
vascular bed specific. In this context, the finding of
conserved changes across different preparations is rele-
vant, as it may reflect obligatory associations of certain
channels with vascular remodeling, representing novel
therapeutic opportunities.
With this idea, we explored the functional expression
and the contribution to VSMC proliferation of the genes
upregulated by the PM. We focused on Kv1.3 channels
because the tools for determining the contribution of the
modulatory subunit Kv2 are more limited. Furthermore,
the concomitant increased expression of Kv1.3 and Kv2
may reflect the fact that they form heteromultimers,
because Kv2 preferentially associates with Kv1.x chan-
nels,28 and both association and upregulation of Kv1.3
and Kv2 have been described on mitogen-stimulated
activation of T lymphocytes.17,29 Functional expression of
Kv1.3 proteins increased in both proliferative models, and
selective blockade of Kv1.3 currents decreased cultured
VSMC migration and proliferation, demonstrating a link
between Kv1.3 channels functional expression and PM.
Finally, although Kv1.3 inhibition leads to VSMC depo-
larization, proliferation was not affected if depolarization
was induced with other channel blockers or with high
[K]e.
However, Kv1.3 inhibition could restrain hyperpolariz-
ing signals required for proliferation. This hypothesis is
consistent with our results showing an attenuated response
to MgTx in high [K]e.
We have previously reported a similar association be-
tween Kv3.4 channel upregulation and proliferation in
human uterine artery VSMCs,8 although in this prepara-
tion, high [K]e depolarization mimics proliferation inhi-
bition by Kv3.4 blockade.30 Interestingly, the Kv1.3 gene
is also upregulated in these cells,8 and Kv1.3 blockers
inhibit proliferation (Supplemental Figure VIB and VIC),
suggesting that the association between Kv1.3 upregula-
tion and proliferation may be present in different vascular
beds. In fact, the ion channel expression profile of cultured
mesenteric VSMCs shows a remarkable similarity to that
of femoral arteries (Supplemental Figure V), with Kv1.3
being the predominant Kv1 channel gene and Kv1.3
blockade inhibiting proliferation.
Kv1.3 channels have been reported to associate with
proliferation in T cells,17 endothelial cells,31 microglia,
macrophages, oligodendrocyte progenitors, and carcinoma
cells,32,33 but this is the first description of their role in
VSMC proliferation and migration. In this scenario, Kv1.3
blockade could represent a new therapeutic approach to
prevent unwanted remodeling.
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SUPPLEMENTAL MATERIAL 
MATERIAL AND METHODS 
Animals and tissues 
BPN strain mice were purchased from Jackson Laboratories (Bar Harbor, Maine, USA) and 
maintained with inbred crossing in the animal facilities of the Schools of Medicine of Valladolid and 
Barcelona. Animals were housed under temperature-controlled conditions (21°C) with free access to 
water and food. Animal protocols were approved by the Institutional Care and Use Committee of the 
Universities of Valladolid and Barcelona, and are in accordance with the European Community guiding 
principles in the care and use of animals.  
Uterine arteries were obtained from patients subjected to hysterectomy at the Clinic Hospital of 
Barcelona, with protocols approved by the Human Investigation Ethic Committee of the Hospital.  
Surgical procedures and collection of arterial samples 
For the transluminal injury of femoral arteries, mice were anesthetized using isoflurane inhalation (5 % 
at 2.5 l O2 min-1). Endoluminal lesion to the common femoral artery was achieved by 3 passages of a 
0.25-mm-diameter angioplasty guidewire (Advanced Cardiovascular Systems) as previously 
described1. Briefly, a groin incision was made under a surgical microscope (Carl Zeiss), the femoral 
artery was temporarily clamped at the level of the inguinal ligament, and an arteriotomy was made 
distal to the epigastric branch. The guidewire was then inserted, the clamp removed, and the wire 
advanced to the level of the aortic bifurcation and pulled back. After removal of the wire, the 
arteriotomy site was ligated. Control sham-operated arteries underwent dissection, temporary 
clamping, arteriotomy, and ligature, without passage of the wire. The right femoral artery of mice 
underwent injury and the left artery was sham-operated and used as control.  
To collect arterial samples mice were killed by decapitation after isofluorane anesthesia. VSMCs from 
femoral, mesenteric and aorta arteries were obtained after carefully dissection and cleaning of 
connective and endothelial tissues, and then arteries were either frozen at -80 ºC to further extract 
RNA or used directly to obtain tissue explants or fresh dispersed VSMCs.  
For the removal of endothelium, we explored the efficiency of chemical and mechanical methods by 
measuring the reduction in the expression of endothelial nitric oxide synthase (eNOS) using clean 
arteries with intact endothelium as the calibrator (see online supplemental figure I). In the light of these 
results, we combined detergent treatment (by perfusion of the arterial lumen during 10 min with a 
0.1% Triton X-100 solution at a pressure of 80 mm Hg) followed by longitudinal section of the arteries 
and manual scrapping of the inner surface with a pipette tip to remove endothelium from the samples. 
Parallel measurements of calponin (Cnn1) mRNA levels were carried out in the same samples to 
ensure that the removal method did not produce changes in the smooth muscle layer.  
At the indicated times after transluminal injury, femoral arteries were obtained from these mice as 
indicated above. However, the proliferative response after endoluminal lesion precluded the 
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identification and removal of endothelium in these samples, and consequently contralateral, sham-
operated femoral arteries were also collected with intact endothelium to serve as controls. This control 
group was designated as CE+, while the endothelium-free arterial samples were labelled as CE-. The 
differences in the expression profile of the genes under study between these two conditions (CE+ and 
CE-) were also addressed (see below). 
VSMCs isolation 
For dispersed cells, small pieces of endothelium-free artery were placed in SMDS Ca2+ free solution 
containing 0.4 mg/ml Papain (Worthington), 1 mg/ml BSA (Sigma) and 1 mg/ml DTT (Sigma) and 
incubated at 37 ºC for 20 min in a shaking water bath. After two washings in SMDS 10μM Ca2+ a 
second 25 min incubation was performed with SMDS 10μM Ca2+ in a 0.28 mg/ml collagenase F, 0.12 
mg/ml collagenase H (Sigma) and 1 mg/ml BSA solution. Single cells were obtained by gentle 
trituration with a wide-bore glass pipette, stored at 4 ºC and used within the same day. Ionic 
composition of SMDS was (in mM): NaCl 145; KCl 4.2; KH2PO4 0.6; MgCl2 1.2; Hepes 10; Glucose 11. 
pH was adjusted to 7.4 with NaOH.  
For the isolation of VSMCs from injured arteries, a different dissociation protocol was employed, 
based on a previously described method2. Briefly, after careful dissection of connective tissue, small 
pieces of artery were placed in 200 µL of culture media (D-MEM medium supplemented with 10% 
FBS, penicillin-streptomycin (100 U/ml each), 5 µg/ml fungizone and 2 mM L-glutamine) containing 
1.36 mg/ml collagenase type I (Worthington), and left in the incubator (at 37 ºC in a 5% CO2 
humidified atmosphere) for four to six hours. After that, 3 ml of culture media were added and cells 
were transfer to a conical tube and centrifuged for 5 min at 300xg. The pellet was resuspended in a 
small volume of culture medium and dispersed cells were plated onto poly-L-lysine coated coverslips 
with 2ml of culture medium supplemented with 1% FBS and maintained in the incubator. 
Electrophysiological experiments were performed within 4-24h after isolation. Parallel studies were 
performed with VSMCs isolated from contralateral control arteries to confirm that the isolation and 
culture conditions did not modify the expression pattern of ion channels observed in acutely dispersed 
VSMCs.   
VSMCs culture 
After carefully dissection and cleaning of connective and endothelial tissues, small pieces of femoral, 
mesenteric or uterine arteries were placed in a 35 mm culture dish covered with 2 % gelatin (Type B 
from bovine skin, Sigma) in DMEM supplemented with 20 % SFB, penicillin-streptomycin (100 U/ml 
each), 5 µg/ml fungizone, and 2 mM L-glutamin (Lonza) at 37 ºC in a 5% CO2 humidified atmosphere. 
Migration and proliferation of VSMCs from the explants was evident within 6-10 days. When cells 
reached confluence, they were detached by exposure to trypsin-EDTA (Lonza) during 3-7 minutes 
followed by mechanical scraping with a rubber spatula. They were then seeded in a new culture plate 
at a 1/3 density in SMC-P-STIM medium: D-MEM medium supplemented with 5% FBS, penicillin-
streptomycin (100 U/ml each), 5 µg/ml fungizone, L-glutamine (2 mM), Insulin (5 µg/ml), bFGF (2 
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ng/ml) and EGF (0.5 ng/ml). VSMCs were subjected to several (3-4) passages without showing 
morphological changes. 
To determine the effect of membrane depolarization on femoral VSMCs proliferation rate, cells were 
placed in culture media with increased K+ concentrations (5, 10 and 20 mmol/L). These media were 
reconstituted with MEM amino acids solution (M5550, Sigma), MEM non-essential amino acid solution 
(M7145, Sigma), MEM Eagle vitamin mix (13-607C, BioWhittaker®) and a buffer composition identical 
to DMEM, except that Na+ and K+ concentrations were varied to maintain osmolarity. In all cases, 
parallel experiments were carried out using the control medium (SMC-P-STIM) as a control of the 5 
mM K+-reconstituted medium. 
RNA Isolation, RT and real time PCR 
Total RNA from arteries was isolated with MELT™ Total RNA Isolation System Kit (Ambion) as 
previously described3. 6-10 femoral arteries (or 20-30 mesenteric arteries or 5-6 aorta arteries) were 
employed for each determination. Total RNA from cultured VSMCs and HEK293 cells were isolated 
with Trizol Reagent (Invitrogen) using 3-5 35 mm culture dishes with cells closed to confluency. In the 
case of cultured VSMCs, we used cells proceeding from several arteries from different animals for 
each experiment. The quality of the RNA was assayed by OD measurement at 260 and 280 nm and 
by electrophoresis on agarose gels. After DNAse I (Ambion) treatment, 500-750 ng of RNA were 
reverse transcribed with 5000 u/ml of MuLvRT in the presence of 20 u/μl of RNAse inhibitor, 50 μM 
Random Hexamers, 10X PCR buffer, 25 mM MgCl2 and 10 mM mixed dNTPs at 42 ºC for 60 min, to 
get cDNA (RT+). All reagents were from Applied Biosystems. From the same samples, 200-350 ng of 
total RNA were used as genomic control in reverse transciptase reaction in the absence of MuLv and 
RNase Inhibitor at 42 ºC for 60 min (RT-). A small fraction of these cDNAs was used for real-time 
amplifications of selected control genes (Gapdh and Gusb) to compare the different samples, and 
also, given the intronless nature of the mGapdh gene, to check the efficiency of the DNAse treatment 
by comparing expression levels of the gene between RT+ and RT- samples. 
The mRNA expression levels were determined by real-time PCR in a Rotor-Gene 3000 (Corbett 
Research) thermocycler using TaqMan® Gene Expression Assays or SYBR Green I with PCR primer 
sets designed with the Primer 3 website (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi). 
Real-time PCR with TaqMan Low Density Arrays (Applied Biosystems) was carried out by the 
Genomic Service of the CNIC (Madrid, Spain), with the ABI Prism 7900HT Sequence detection 
system (Applied Biosystems) and data were acquired with SDS 2.1 software. mRNA expression levels 
were determined using the threshold cycle (Ct) relative quantification method (ΔΔCt)4.  
Expression data of genes were normalized by an internal control, ribosomal (RNA 18s, Gapdh or 
Gusb). The relative abundance of the genes was calculated from 2(-ΔCt), where  
ΔCt=Ctgen-Ctinternal control  
Changes in the expression between control (calibrator) and the different experimental conditions were 
calculate from 2 (-ΔΔCt), where  
ΔΔCt = ΔCtexperimental–ΔCtcalibrator 
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In order to do statistical comparisons, ΔCt values obtained in each sample, (Ctgen–Ctinternal control), were 
subtracted from the mean ΔCt of the calibrator to provide the SE. In the cases in which expression of 
a gene was not detected in one of the conditions, a Ct value of 40 was assigned in order to do the 
comparisons.  
Primers,TaqMan probes and TaqMan® Gene Expression Assays (Applied Biosystems) used (the list 
of genes studied with the Taqman® Low Density Arrays is provided in Table I):  
mGapdh: 5’-TGTGTCCGTCGTGGATCTG-3’, 5’- GATGCCTGCTTCACCACCTT-3’ and 5’-FAM-
TGGAGAAACCTGCCAAGTATGATGACATCA-BHQ2-3’;  
mGusb: 5’-CAATGGTACCGGCAGCC-3’, 5’-AAGCTAGAAGGGACAGGCATGT-3’ and 5’-FAM-
TACGGGAGTCGGGCCCAGTCTTG-BHQ2-3’. 
mCnn1: 5'-ACAAGAGCGGAGATTTGAGC-3' and 5'-TGAGTGTGTCGCAGTGTTCC-3' 
meNos: 5’-GCATCACCAGGAAGAAGACC-3’ and 5’-GGGACACCACATCATACTCATC-3’ 
hGUSB: 5'-ACCAGGGACCATCCAATACC-3' and 5'-CATCCAAAAGACGCACTTCC-3' 
mKcna3: Mm00434599_s1 
hCNN1: Hs00154543_m1  
Data analysis 
Data from the TaqMan® Low Density Arrays were analyzed with several independent methods. A two-
way hierarchical clustering was applied to the gene-expression matrix consisting on the cards of the 
different conditions explored and the genes with significant expression in at least one of the 
experimental conditions. The values introduced for each gene were the ΔCt of each experiment (the 
mean ΔCt of the duplicates). We used the Cluster software5 and applied average linkage clustering 
with uncentered correlation after array normalization. Clusters were visualized using the Treeview 
software. Relationships among genes are represented by a tree whose branch lengths reflect their 
degree of similarity assessed by a pairwise similarity function. The computer trees are used to order 
the genes in the original data table, so that groups of genes with similar expression pattern are 
adjacent. When this ordered table is displayed graphically, the presence of contiguous patches of 
colour can be readily identified. A second method of analysis was the determination in each 
experimental conditions of the relative expression of each gene to obtain its 2(-ΔCt) value. The averaged 
(mean ± SEM) ΔCt values for each gene in control versus proliferative conditions were used to obtain 
the differences in expression (2(-ΔΔCt)) between both conditions as indicated above, and statistical 
differences were determined with a student t-test. Finally, the ΔCt values of all the genes from each 
array were compared in the different situations with an analysis of variance (in the case of endoluminal 
lesion) or a t-test (in the case of cultured femoral VSMCs) to test for mean differences between the 
groups. The obtained p-values were adjusted for multiple testing with the false discovery rate (FDR) 
control6 using the tools for differential gene expression of the suite of programs GEPAS 
(http://gepas.bioinfo.cipf.es/). The choice of a high enough posterior probability of differential 
expression is considered to control for the multiplicity of tests performed. 
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Histology and immunohistochemistry 
For the morphometric and immunohistochemical analysis, animals were euthanized 48 hours, 1 and 4 
weeks after arterial injury and perfusion-fixed with 4% paraphormaldehyde in PBS for 5 min at 100 
mmHg to obtain paraffin sections from femoral arteries as described in previous studies1. Three 5-µm-
thick paraffin sections from each arterial segment were stained with combined Masson’s trichrome 
elastic and analyzed by using computerized morphometry (NIH Image) and the average values were 
calculated. Measurements included luminal area, medial area, intimal area, vessel area, and the 
lengths of the internal elastic lamina and external elastic lamina. From these data, the intima-to-media 
(I/M) ratio (IA/MA), and the percentage of luminal stenosis (100·IA/(LA + IA)) was calculated as 
previously described1. The percentage of stenosis obtained were 35±7.24% for 1 week after lesion and 
75.64±4.82 for 4 weeks after lesion.  
For immunohistochemical analysis, paraffin sections were deparaffined, rehydrated, treated with 1% 
citric acid for antigen retrieval and blocked with 3% hydrogen peroxide (DakoCytomatation) before the 
incubation with primary antibodies at 4°C ON. Sections were washed in PBS, incubated with a 
horseradish peroxidase conjugated anti-mouse IgG (DakoCytomatation) for 30 minutes at room 
temperature (RT). Signal was detected using 3,3-diaminobenzidine (DAB, DakoCytomatation). After 
being washed in distilled water, all sections were counterstained with hematoxylin. Negative controls 
were prepared by substitution of the primary antibody with an irrelevant antibody. Primary antibodies 
used were: mouse anti-Kv1.3 (clone L23/27) and mouse anti-Kv1.5 (clone K7/45) both from Neuromab 
(UC Davis NIH and Antibodies Inc.). Immunohistochemical measurements were performed as follows: 
four magnified (x 20) areas of the vessel wall, acquired from each of the four quadrants of the arterial 
circumference, were blindly analyzed (Image AnalySIS 2.3). The percentage of labelled area over the 
total vessel area was calculated for all arteries. 
Immunocytochemistry 
Freshly isolated VSMCs plated onto glass coverslips were allowed to set for 30 min at RT, and 
cultured VSMCs were directly seed in coverslips placed in the bottom of petri dishes 2-3 days before 
the immunoflourescence assay. Cells were fixed with 4% paraformaldehyde (PF) in phosphate buffer, 
pH 7.5, for 15 min at 20 ºC, washed in PBTx (PBS, 0.1% Triton X-100), and blocked with PBTx with 
2% of normal goat serum for 10 min. Primary antibodies were diluted in blocking solution and 
incubated with the cells for 60 min at RT at final dilutions indicated below. After washes in PBTx, cells 
were incubated with secondary antibodies for 30 min. The fluorescently labelled secondary antibodies 
(Alexa 488 goat anti-mouse/rabbit secondary antibodies -Molecular Probes-) were used at a final 
dilution of 1:1000. After washes in PBS, the coverslips were mounted with Vectashield H-1000 (Vector 
Labs) with DAPI, and photomicrographs were acquired with Nis-element software (Nikon). 
The primary antibodies used and their final dilution were: mouse anti-Kv1.3 (1:33, NeuroMab, 
Antibodies Inc.), rabbit anti-Kv1.5 (1:50, Sigma), mouse anti-SMαA (1:100), rabbit anti-Calponin (1:50) 
and anti-SM22 (1:50) (abcam, ab7817, ab46794 and ab14106 respectively). 
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Electrophysiological methods 
Ionic currents were recorded at RT (20-25 ºC) using the whole-cell configuration of the patch-clamp 
technique as previously described3;7. The coverslips with the attached cultured VSMCs were placed at 
the bottom of a small recording chamber (0.2 ml) on the stage of an inverted microscope and perfused 
by gravity with the bath solution, while freshly isolated VSMCs were placed directly on the recording 
chamber and let to sit for a few minutes before starting superfusion with the external solution. Patch 
pipettes were made from borosilicate glass (2.0 mm O.D., WPI) and double pulled (Narishige PP-83) 
to resistances ranging from 7 to 10 MΩ for VSMCs when filled with an internal solution, containing 
(mM): 125 KCl, 4 MgCl2, 10 HEPES, 10 EGTA, 5 MgATP; (pH 7.2 with KOH). The composition of the 
bath solution was (mM): 141 NaCl, 4.7 KCl, 1.2 MgCl2, 1.8 CaCl2, 10 glucose, 10 HEPES, (pH 7.4 with 
NaOH). Whole-cell currents were recorded using an Axopatch 200 patch-clamp amplifier, filtered at 2 
kHz (-3 dB, 4-pole Bessel filter), and sampled at 10 kHz. When leak-subtraction was performed, an 
online P/4 protocol was used. Recordings were digitized with a Digidata 1200 A/D interface, driven by 
CLAMPEX 8 software (Axon Instruments) in a Pentium clone computer. 
Current-voltage relationships were obtained from a holding potential of –80 mV in 10 mV depolarizing 
steps from –60 to +80 mV during 200 ms. Paxilline, tetraethylammonium chloride (TEA) and PAP-1 
were obtained from Sigma, Margatoxin and Stromatoxin were from Alomone Labs, and correolide was 
a gift from Dr. María García (Merck).  
Electrophysiological data analyses were performed with the CLAMPFIT subroutine of the PCLAMP 
software (Axon) and with ORIGIN 7.5 software (Microcal Inc.). Pooled data are expressed as mean± 
standard error of the mean (SEM). Statistical comparisons between groups of data were carried out 
with the two-tailed Student t test for paired or unpaired data, and values of p<0.05 were considered 
statistically different.  
Membrane potential (VM) measurements were performed at RT using the perforated-patch technique 
to avoid dialysis of intracellular medium. For these experiments, recordings were obtained with an 
Axopatch 4A patch-clamp amplifier. Pipette tips were briefly dipped into a solution containing (in mM): 
40 KCl, 95 KGlutamate, 8 CaCl2, 10 HEPES, pH 7.2 with KOH, and backfilled with the same solution 
containing amphotericin B (480 µg/ml). After obtaining a high-resistance seal, electrical access to cell 
cytoplasm was assessed by monitoring the increase in cell capacitance. At this point, the amplifier 
was switched to current-clamp mode and membrane potential was continuously recorded. The high 
Ca2+ content of the pipette solution ensures the correct performance of the perforate-patch technique, 
as accidental rupture of the patch (changing to whole-cell configuration) would lead to a sudden Ca2+ 
load and cell death. The composition of the bath solution was the same that the indicated for the 
voltage-clamp experiments, except for the experiments exploring the effect of high extracellular K+, in 
which Na+ concentration in the external solution was reduced equimolarly. 
Cell Migration assay 
To evaluate migration we used a wound healing or scratch assay 8, in cultured VSMCs from mouse 
femoral arteries. Cells were seeded in 4-well plates (1.8 cm2/well) and grown in SMC-P-STIM medium 
until confluence. Monolayers were manually scraped with a 200 μl pipette tip, gently washed three 
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times with PBS to remove non-adherent cells, and incubated in a serum free medium (SF medium) to 
block proliferation. The SF medium is a DMEM supplemented with 500 nM insulin, 5 µg/ml transferrin 
100 U/ml each penicillin and streptomycin, 5 µg/ml fungizone, and 2 mM L-glutamine. Images of the 
scratched area were taken immediately (time 0) and 24 hours after injury. The scratched area was 
measured using Image J software. Percentage of invaded area was determined as 
% Reinvasion=100·(Area0-Area24)/Area0 
where Area0= initial area (t=0) and Area24= area at time 24 h after injury. 
Migration assays were performed in the absence (control) or presence of 10 nM PAP-1 or margatoxin.  
Proliferation assays 
Femoral, mesenteric or uterine cultured VSMCs were plated in poli-L-lysine coated coverslips and 
grown to approximately 65-80 % confluence. At this point, cells were synchronized by incubation 
during 48-72 h in SF medium at 37 ºC in a 5% CO2 humidified atmosphere. After this, cells were either 
maintained in SF medium (negative control), placed in SMC-P-STIM medium alone (control) or SMC-
P-STIM medium with 10 nM Margatoxin, 10 nM PAP-1, 50 nM Stromatoxin, 500 nM Paxilline or 
culture media with high (10 or 20 mM) K+ concentrations (experimental conditions) during 24h. At the 
end of this period, BrdU incorporation assay were performed by incubation with the BrdU labeling 
medium for 60 min at 37 ºC in a 5% CO2 humidified atmosphere and then fixed with 50 mM glycine 
solution in 70% ethanol for 20 min at -20 ºC. Incorporated BrdU was detected by 30 min incubation at 
37ºC with anti-BrdU, followed by 30 min incubation at 37ºC with anti-mouse-Ig-fluorescein, according 
to manufacturer’s instructions (Roche Applied Science, Germany). Coverslips were mounted in 
Vectashield with DAPI (Vector Laboratories, INC., Burlingame, CA), and BrdU incorporation was 
measured and represented as the percentage of BrdU positive cells (BrdU+) from the total cell number 
stained with DAPI. In each experiment, BrdU incorporation was obtained from the average of at least 
10 different fields for each condition. 
siRNA transfections 
Femoral cultured VSMCs were plated in poli-L-lysine coated coverslips in 4-well plates (1.8 cm2/well, 
NuncTM) at 60%–70% confluence. Cells were incubated in SF medium 24 h prior to transfection. 
Transfections were performed using 35 nM of siRNA (Applied Biosystems) and 1.2 μl of 
LipofectamineTM 2000 (Invitrogen) following manufacturer instructions, 24h after transfection cells 
were placed in SMC-P-STIM medium at 37 ºC in a 5% CO2 humidified atmosphere. A high 
transfection efficiency (>80%) was determined by transfection with BLOCK-iT™ Fluorescent oligo 
(Invitrogen), and detection of the fluorescence signal at 24 h post-transfection using fluorescence 
microscopy. siRNA validations were performed in culture femoral cells that were either mock-
transfected (control), transfected with negative control siRNA or with siRNA against Kv1.3. The 
reduction in the expression of Kv1.3 upon siRNA transfection was evaluated at 48h post-transfection 
at the mRNA level by quantitative PCR, using Gapdh as housekeeping and mock-transfected cells as 
calibrator. The Kv1.3 siRNA tested were: s68583 (siRNA1), s68585 (siRNA2) and the siRNA negative 
control 4390843 (Applied Biosystems). BrdU incorporation was determined 48 h post- transfection. 
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ADDITIONAL FIGURES AND SUPPORTING INFORMATION 
List of genes studied with the Taqman® low-density array 
The list of the genes whose expression was explored in this study is provided in Table I. The 
information provided includes the gene name (the nomenclature used through the paper), the gene 
symbol, the Applied Biosystem ID of the Taqman® assay and the Genbank accession number of the 
nucleotide sequence. The array lacks some α and β subunits of the K+ channel family, as well as 
some α subunits of other channel families studied (i.e. Trp channels or Cl- channels) due to the fact 
that they were not available as inventoried Taqman® assays at the moment this study started. 
Table I. Genes explored in the study 
Gene Name Gene Symbol Assay ID NCBI Gene Ref Category 
18S RNA 18SRNA Hs99999901_s1 X03205.1 endogenous control 
SUR2 Abcc9 Mm00441638_m1 NM_011511.1,NM_021041.1, K+ channel 
B2m B2m Mm00437762_m1 NM_009735.2 endogenous control 
Cav1.2 Cacna1c Mm00437917_m1 NM_009781.1 Ca2+ channel 
Cav1.3 Cacna1d Mm00551384_m1 NM_028981.1 Ca2+ channel 
Cav3.1 Cacna1g Mm00486549_m1 NM_009783.1 Ca2+ channel 
Cav3.2 Cacna1h Mm00445369_m1 NM_021415.3 Ca2+ channel 
Cav1.1 Cacna1s Mm00489257_m1 AW493108 Ca2+ channel 
Clca1 Clca1 Mm00777368_m1 NM_009899.2 Cl- channel 
Clca2 Clca2 Mm00661630_m1 NM_030601.2 Cl- channel 
Clca3 Clca3 Mm00489959_m1 NM_017474.1 Cl- channel 
Clca4 Clca4 Mm00519742_m1 NM_139148.1 Cl- channel 
Clca5 Clca5 Mm00724513_m1 NM_178697.3 Cl- channel 
Clcn3 Clcn3 Mm00432566_m1 NM_173876.2,NM_007711.2 Cl- channel 
Cnn1 Cnn1 Mm00487032_m1 NM_009922.2 cytoskeletal protein 
Gapdh Gapdh Mm99999915_g1 NM_001001303.1 endogenous control 
Hprt1 Hprt1 Mm00446968_m1 NM_013556.2 endogenous control 
Kv1.1 Kcna1 Mm00439977_s1 NM_010595.2 K+ channel 
Kv1.2 Kcna2 Mm01546131_g1 NM_008417.2 K+ channel 
Kv1.3 Kcna3 Mm00434599_s1 NM_008418.1 K+ channel 
Kv1.4 Kcna4 Mm01336166_m1 NM_021275.2 K+ channel 
Kv1.5 Kcna5 Mm00524346_s1 NM_145983.1 K+ channel 
Kv1.6 Kcna6 Mm00496625_s1 NM_013568.4 K+ channel 
Kvbeta1 Kcnab1 Mm00440018_m1 NM_010597.2 K+ channel 
Kvbeta2 Kcnab2 Mm00440022_m1 NM_010598.2 K+ channel 
Kvbeta3 Kcnab3 Mm00440034_g1 NM_010599.2 K+ channel 
Kv2.1 Kcnb1 Mm00492791_m1 NM_008420.3 K+ channel 
Kv3.1 Kcnc1 Mm00657708_m1 NM_008421.2 K+ channel 
Kv3.3 Kcnc3 Mm00434614_m1 NM_008422.1 K+ channel 
Kv3.4 Kcnc4 Mm00521443_m1 NM_145922.1 K+ channel 
Kv4.1 Kcnd1 Mm00492796_m1 NM_008423.1 K+ channel 
Kv4.2 Kcnd2 Mm00498065_m1 NM_019697.3 K+ channel 
Kv4.3 Kcnd3 Mm00498260_m1 NM_019931.1 K+ channel 
Mink Kcne1 Mm00434615_m1 NM_008424.3, X60457.1 K+ channel 
MiRP1 Kcne2 Mm00506492_m1 NM_134110.1 K+ channel 
MiRP2 Kcne3 Mm00445119_m1 NM_020574.3 K+ channel 
Kv6.3 Kcng3 Mm00463328_m1 NM_153512.1 K+ channel 
Kv10.1 Kcnh1 Mm00495110_m1 NM_010600.2 K+ channel 
Kv11.1(erg-1) Kcnh2 Mm00465370_m1 NM_013569.1 K+ channel 
Kv11.3(erg-3) Kcnh7 Mm00713030_m1 NM_133207.1 K+ channel 
KChIP1 Kcnip1 Mm00471928_m1 NM_027398.2 K+ channel 
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KChIP2 Kcnip2 Mm00518914_m1 NM_030716.2,NM_145703.1 K+ channel 
KChIP3 Kcnip3 Mm00490739_m1 NM_019789.2 K+ channel 
KChIP4 Kcnip4 Mm00518835_m1 NM_030265.2 K+ channel 
Kir4.1 Kcnj10 Mm00444727_s1 NM_019659.2 K+ channel 
Kir6.2 Kcnj11 Mm00445028_m1 NM_001039484.1 K+ channel 
Kir2.2 Kcnj12 Mm00440050_s1 NM_010602.2 K+ channel 
Kir1.1 Kcnj1 Mm01237201_m1 NM_010603.3 K+ channel 
Kir2.1 Kcnj2 Mm00434616_m1 NM_008425.2 K+ channel 
Kir3.1 Kcnj3 Mm00434618_m1 NM_008426.1 K+ channel 
Kir3.2 Kcnj6 Mm00440070_m1 NM_001025584.2, NM_010606.2  K+ channel 
Kir6.1 Kcnj8 Mm00434620_m1 NM_008428.2 K+ channel 
Kir3.3 Kcnj9 Mm00434622_m1 NM_008429.2 K+ channel 
TWIK1 Kcnk1 Mm00434624_m1 NM_008430.1 K+ channel 
TREK1 Kcnk2 Mm00440072_m1 NM_010607.1 K+ channel 
TASK1 Kcnk3 Mm00807036_m1 NM_010608.2 K+ channel 
TRAAK Kcnk4 Mm00434626_m1 NM_008431.1 K+ channel 
TASK2 Kcnk5 Mm00498900_m1 NM_021542.2 K+ channel 
BK Kcnma1 Mm00516078_m1 NM_010610.2 K+ channel 
BKbeta1 Kcnmb1 Mm00466621_m1 NM_031169.2 K+ channel 
BKbeta2 Kcnmb2 Mm00511481_m1 NM_028231.2 K+ channel 
BKbeta4 Kcnmb4 Mm00465684_m1 NM_021452.1 K+ channel 
SK1 Kcnn1 Mm00446259_m1 NM_032397.1 K+ channel 
SK2 Kcnn2 Mm00446514_m1 NM_080465.1 K+ channel 
SK3 Kcnn3 Mm00446516_m1 NM_080466.1 K+ channel 
SK4(IK1) Kcnn4 Mm00464586_m1 NM_008433.2 K+ channel 
Kv9.1 Kcns1 Mm00492824_m1 NM_008435.2 K+ channel 
Kv9.2 Kcns2 Mm00492825_g1 NM_181317.3 K+ channel 
Kv9.3 Kcns3 Mm00557826_m1 NM_173417.1 K+ channel 
Klf5 Klf5 Mm00456521_m1 NM_009769.2 proliferation marker  
Nos3 Nos3 Mm00435204_m1 NM_008713.2 endotelial cell marker 
KChAP Pias3 Mm00450739_m1 NM_146135.1,NM_018812.1 K+ channel 
Trpp1 Pkd1 Mm00465434_m1 NM_013630.1 TRP channel 
Trpp2 Pkd2 Mm00435829_m1 NM_008861.2 TRP channel 
Trpp5 Pkd2l2 Mm00450423_m1 NM_016927.1 TRP channel 
Trpc1 Trpc1 Mm00441975_m1 NM_011643.1 TRP channel 
Trpc2 Trpc2 Mm00441984_m1 NM_011644.1 TRP channel 
Trpc3 Trpc3 Mm00444690_m1 NM_019510.1 TRP channel 
Trpc4 Trpc4 Mm00444284_m1 NM_016984.1 TRP channel 
Trpc5 Trpc5 Mm00437183_m1 NM_009428.1 TRP channel 
Trpc6 Trpc6 Mm00443441_m1 NM_013838.1 TRP channel 
Trpc7 Trpc7 Mm00442606_m1 NM_012035.1 TRP channel 
Trpm1 Trpm1 Mm00450619_m1 NM_018752.2 TRP channel 
Trpm2 Trpm2 Mm00663098_m1 NM_138301.1 TRP channel 
Trpm3 Trpm3 Mm00616485_m1 NM_177341.3 TRP channel 
Trpm4 Trpm4 Mm00613173_m1 NM_175130.2 TRP channel 
Trpm5 Trpm5 Mm00498453_m1 NM_020277.1 TRP channel 
Trpm6 Trpm6 Mm00463112_m1 NM_153417.1 TRP channel 
Trpm7 Trpm7 Mm00457998_m1 NM_021450.1 TRP channel 
Trpm8 Trpm8 Mm00454566_m1 NM_134252.2 TRP channel 
Trpv2 Trpv2 Mm00449223_m1 NM_011706.1 TRP channel 
Trpv3 Trpv3 Mm00454996_m1 NM_145099.1 TRP channel 
Trpv4 Trpv4 Mm00499025_m1 NM_022017.1 TRP channel 
Trpv6 Trpv6 Mm00499069_m1 NM_022413.2 TRP channel 
Vwf Vwf Mm00550376_m1 NM_011708.2 endotelial cell marker 
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Statistical analysis of the differential gene expression in the two proliferation 
models 
As mentioned above, several independent methods have been used to analyze the data obtained in 
the low density Taqman® arrays. First we analyzed the differences in expression for each individual 
gene. In this case, ΔCt values for each gene in control (contractile) conditions were used as calibrator, 
and the fold-change upon proliferation was calculated using the 2(-ΔΔCt) relative quantification method 4. 
Significant changes in expression were determined with a student t-test (in the case of in vitro 
proliferation) or with an Anova test (for the in vivo lesions at different time points). Genes showing 
statistically significant changes in their expression are shown in Figure III in which the log of 2(-ΔΔCt) 
was used for representing the data, so that a value of 0 means no change, positive values represent 
increased expression and negative values decreased expression.   
A different analysis method was used for the diagram shown in figure 2C, that has been constructed 
from the output of the statistical analysis of the data in GEPAS suite. The T-Rex set of programs (used 
for analyzing differential gene expression) provides estimates for statistics, p-values and posterior 
probabilities that are used to order genes in terms of their pattern of differential expression. When 
appropriate, p-values adjusted for multiple testing are provided, and in this case, three methodologies 
are implemented. One of them, the method proposed by Holm (fwer.holm) controls the FWER (family-
wise error rate). The other two methods control the FDR (false discovery rate), one using the algorithm 
proposed by Benjamini & Hochberg 9 (fdrBH) and the other one implementing the q values method 
proposed by Storey10. 
The following tables show all the data provided by this analysis in the two conditions explored: 
Differential gene expression when comparing tissue versus cultured VSMCs (Table II) and differential 
gene expression in the endoluminal lesion at different times, by using multi-class option in T-Rex 
(Table III). The first analysis uses an statistical method based on t-test, where increased and decrease 
expression are indicated with positive and negative values on the column labelled as “statistic”, while 
in the second approach the differential gene expression was evaluated by an Anova test and all the 
statistic values are positive regardless of whether they reflect increased or decreased expression 
referred to the control data. In both analysis, we selected genes (shown in bold) showing a fdrBH 
correction of the p-value below 0.05.  
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Table II- Statistics of the differential gene expression in the cultured VSMCs 
genename Statistic pvalue fwer.holm fdrBH Q value 
Kvbeta2 8.17370701 0.00121993 0.0646563 0.00780945 6.57E-05 
Kv3.3 7.8563261 0.00141828 0.07233232 0.00780945 6.57E-05 
Kv1.4 5.95294952 0.00399612 0.17982556 0.01445634 0.00012155 
TREK1 5.57012415 0.00508973 0.21885853 0.01628148 0.0001369 
Kv10.1 5.25077105 0.0062939 0.24546191 0.01716517 0.00014433 
Kir2.1 3.83103347 0.01860164 0.61385403 0.03986065 0.00033515 
Kv1.3 3.64932156 0.02178451 0.69710434 0.0448444 0.00037706 
Kv4.1 3.29808426 0.02998722 0.86962937 0.05622604 0.00047276 
Trpp2 2.58948827 0.06071666 1 0.10851494 0.00091241 
Kv11.1(erg-1) 2.57746506 0.0614918 1 0.10851494 0.00091241 
Cav1.3 1.95279861 0.1225629 1 0.18855831 0.00158543 
Trpm7 1.79068255 0.14783308 1 0.22174962 0.0018645 
Trpc4 1.69386196 0.16554163 1 0.24225605 0.00203692 
SK3 1.61822724 0.18092404 1 0.25245215 0.00212265 
SK4(IK1) 1.53536665 0.19949053 1 0.27203254 0.00228729 
KChIP4 1.3463968 0.24941032 1 0.31839615 0.00267712 
Clca1 1.23468828 0.28451884 1 0.34839041 0.00292932 
Kvbeta3 1.14244211 0.31700847 1 0.38041016 0.00319854 
BKbeta2 0.99427581 0.37636554 1 0.44278299 0.00372298 
Kv4.2 0.90677834 0.41580963 1 0.47978034 0.00403406 
Kv11.3(erg-3) 0.67404014 0.53723198 1 0.59692442 0.00501903 
BKbeta4 0.59900737 0.58144152 1 0.63429984 0.00533328 
Clcn3 0.42667291 0.6915791 1 0.71593862 0.00601971 
Trpm4 0.42593554 0.692074 1 0.71593862 0.00601971 
Trpc6 0.37996328 0.72328609 1 0.73554518 0.00618457 
Trpc3 -0.21835274 0.83784199 1 0.83784199 0.00704469 
TASK2 -0.45515728 0.67260641 1 0.71593862 0.00601971 
Cav3.1 -0.82275116 0.45686874 1 0.51720989 0.00434877 
Kir2.2 -1.29922712 0.26369187 1 0.32961484 0.00277145 
Trpm3 -1.39990246 0.23412763 1 0.30538386 0.00256771 
Trpp1 -1.51286447 0.20486273 1 0.2731503 0.00229669 
Trpv4 -1.66192031 0.17186399 1 0.24551998 0.00206437 
Trpc1 -2.20678592 0.09195467 1 0.14519159 0.00122079 
SK1 -2.2110281 0.0915213 1 0.14519159 0.00122079 
Kvbeta1 -2.23344564 0.08926876 1 0.14519159 0.00122079 
Kv1.6 -2.27333283 0.0854127 1 0.14519159 0.00122079 
KChAP -3.33552337 0.02895622 0.86868664 0.0560443 0.00047123 
Cav3.2 -3.61672854 0.0224222 0.69710434 0.0448444 0.00037706 
Kir6.2 -3.90818429 0.01742053 0.59229797 0.03871229 0.0003255 
SK2 -4.00756454 0.01602898 0.56101442 0.03698996 0.00031102 
BK -4.42333794 0.01148113 0.41332077 0.02755472 0.00023168 
SUR2 -4.56965876 0.01026344 0.37974736 0.02565861 0.00021574 
Trpv2 -4.8159337 0.00854828 0.32483479 0.02229987 0.0001875 
Kv9.3 -5.31708384 0.00601738 0.2406952 0.01716517 0.00014433 
Kv2.1 -5.47198963 0.00542716 0.22251359 0.01628148 0.0001369 
TASK1 -5.52488279 0.005242 0.22016411 0.01628148 0.0001369 
Trpc2 -5.91292953 0.00409596 0.18022234 0.01445634 0.00012155 
Kv1.5 -6.12597418 0.00359737 0.16547902 0.01438948 0.00012099 
Cnn1 -6.4240303 0.00301876 0.14271396 0.01293754 0.00010878 
Kv1.1 -6.45044422 0.00297321 0.14271396 0.01293754 0.00010878 
Nos3 -7.83681488 0.00143173 0.07233232 0.00780945 6.57E-05 
Cav1.2 -8.04425144 0.0012964 0.06741296 0.00780945 6.57E-05 
Kir6.1 -8.41477966 0.00109184 0.05895932 0.00780945 6.57E-05 
TWIK1 -8.71250629 0.0009558 0.05256908 0.00780945 6.57E-05 
Kir4.1 -9.92673874 0.00057823 0.03238081 0.00693875 5.83E-05 
Kv4.3 -10.3333073 0.00049494 0.02821165 0.00693875 5.83E-05 
Kv3.4 -11.7948427 0.0002957 0.01715064 0.00591401 4.97E-05 
Kv1.2 -14.4185619 0.00013448 0.00793443 0.00403445 3.39E-05 
BKbeta1 -16.6256809 7.67E-05 0.00460026 0.00403445 3.39E-05 
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Table III- Statistics of the differential gene expression in the endoluminal lesion 
genename Statistic pvalue fwer.holm fdrBH Q value 
Clca1 68.422699 4.80E-06 0.00028793 0.00028793 7.85E-05 
Kv1.5 37.1956978 4.79E-05 0.00282894 0.00143845 0.00039215 
Kv2.1 30.5888004 9.84E-05 0.00570879 0.00196855 0.00053667 
BK 25.3422165 0.00019435 0.01107768 0.00291518 0.00079474 
Cav3.2 21.952261 0.00032374 0.01812945 0.00294281 0.00080227 
Kv1.2 21.7244892 0.00033585 0.01847197 0.00294281 0.00080227 
BKbeta1 21.5890293 0.00034333 0.01853969 0.00294281 0.00080227 
SK3 19.5539131 0.0004853 0.02572096 0.00363976 0.00099227 
Kvbeta2 13.7762737 0.00158793 0.08257252 0.01058622 0.00288603 
Cnn1 13.23421 0.00181115 0.09236887 0.01086693 0.00296255 
Kir6.1 12.5870915 0.00213155 0.10657732 0.01162662 0.00316966 
Kv1.3 12.2040615 0.00235482 0.11538635 0.01177412 0.00320987 
Trpp1 11.5218163 0.00282996 0.1358381 0.01306136 0.0035608 
Kv4.3 10.6687174 0.00360594 0.16947934 0.01545404 0.0042131 
Nos3 9.76977348 0.00473404 0.21776598 0.01790758 0.00488198 
Trpc2 9.74206734 0.00477536 0.21776598 0.01790758 0.00488198 
Trpv2 8.39938259 0.00745375 0.32796477 0.02630734 0.00717193 
Kv3.4 8.15215778 0.00813634 0.34986264 0.02712114 0.00739379 
Kvbeta1 7.88136578 0.00897597 0.37699072 0.02834517 0.00772749 
SUR2 7.02319241 0.01246042 0.51087703 0.03693151 0.0100683 
Kv1.1 6.93146229 0.01292603 0.51704109 0.03693151 0.0100683 
Cav1.2 6.61351538 0.01471745 0.57398064 0.04013851 0.0109426 
Kv4.1 5.9893527 0.0192319 0.73081201 0.05017016 0.01367744 
TASK1 4.7279253 0.03507906 1 0.08769764 0.02390822 
Trpc1 4.60135841 0.03745266 1 0.08831916 0.02407766 
KChAP 4.55998373 0.03827164 1 0.08831916 0.02407766 
Trpm4 3.4096055 0.07343209 1 0.1601327 0.04365553 
Kir6.2 3.38111591 0.07472859 1 0.1601327 0.04365553 
TWIK1 3.21474314 0.08289243 1 0.17150159 0.04675493 
Cav1.1 3.07707214 0.09049527 1 0.1774334 0.04837207 
Clca5 3.0570097 0.09167393 1 0.1774334 0.04837207 
Kv9.3 2.83338904 0.1061855 1 0.19909782 0.05427824 
BKbeta4 2.67937636 0.11784747 1 0.21426813 0.05841399 
SK2 2.62001395 0.12276015 1 0.21663557 0.0590594 
Kir4.1 2.42602682 0.14066966 1 0.24114799 0.065742 
Kv1.6 2.35380507 0.14814732 1 0.24691219 0.06731344 
Cav1.3 2.29947901 0.15409464 1 0.24988319 0.0681234 
MiRP2 2.23147273 0.16195686 1 0.25572136 0.06971501 
Kv3.3 2.11620474 0.17643416 1 0.27143717 0.07399947 
Trpc3 1.95648122 0.19919644 1 0.29879467 0.08145769 
TASK2 1.49995697 0.28689921 1 0.4198525 0.1144606 
KChIP4 1.34342599 0.32717025 1 0.46690215 0.12728732 
Trpm3 1.31698978 0.3346132 1 0.46690215 0.12728732 
Trpc6 1.2618463 0.35078743 1 0.47662318 0.12993747 
Clcn3 1.23993325 0.35746738 1 0.47662318 0.12993747 
Kir2.1 1.16011441 0.38308203 1 0.49967222 0.13622113 
Trpm2 0.97806233 0.44979873 1 0.56957771 0.15527883 
Kvbeta3 0.94547039 0.46308008 1 0.56957771 0.15527883 
Trpv4 0.92449004 0.4718602 1 0.56957771 0.15527883 
KChIP3 0.9179185 0.47464809 1 0.56957771 0.15527883 
Cav3.1 0.70583093 0.57490522 1 0.66447521 0.18114988 
Trpm7 0.69805956 0.57897627 1 0.66447521 0.18114988 
Kv4.2 0.68299091 0.5869531 1 0.66447521 0.18114988 
Kv11.1(erg-1) 0.59965718 0.63306356 1 0.70340395 0.19176267 
Trpc4 0.55176836 0.66109264 1 0.70965177 0.19346596 
Trpm6 0.54967749 0.66234165 1 0.70965177 0.19346596 
SK1 0.34422159 0.79438794 1 0.83619783 0.22796507 
SK4(IK1) 0.21508649 0.88322306 1 0.91367902 0.24908806 
Trpp2 0.17607811 0.90962499 1 0.92504237 0.25218595 
Trpm5 0.14045015 0.93293619 1 0.93293619 0.25433797 
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Study of the phenotypic switch in mesenteric arteries 
In order to elucidate if the observed changes upon proliferation are specific of the vascular bed studied 
(femoral artery) or can be extrapolated to other vessels, we have studied the changes in the 
expression pattern of the ion channels in contractile and proliferative VSMCs from a different vascular 
bed. We choose mesenteric arteries, as they can constitute a paradigm of a resistance vessel, and we 
have also studied the expression pattern of the ion channel genes in a model of conduit vessel as it is 
the case of aortas. Following the same experimental design, we have first explored the relative 
abundance of the different channel genes in this preparation by using mRNA obtained from the 
muscular layer of mesenteric and aorta arteries, with endothelium removed as previously described. 
An overview of the differences in the relative abundance of the channel genes was obtained by a two-
way hierarchical clustering analysis of genes and vascular beds (Supplemental Figure IV). The 
analysis shows that the expression pattern of femoral VSMCs is intermediate between mesenteric an 
aortic VSMCs. However, there were two groups of genes in which expression in femoral arteries was 
either lower than in aorta or mesenteric arteries (marked in blue in the figure), or higher than in the 
other vascular beds (purple frame). Interestingly, the first of these groups includes Kv1.3 and Kvβ2 
genes, and the second one includes IK1 (SK4). As the up-regulation of IK1 and its functional 
contribution to proliferation both in vivo and in vitro has been described in resistance (coronary 11) and 
aortic vessels 12, where no mRNA expression was detected in contractile VSMCs, it is tempting to 
speculate that not only the expression profile of ion channels but also the changes induced upon PM 
could be vascular-bed specific. 
When analyzing individual gene differences between contractile and proliferating VSMCs from 
mesenteric arteries, we found that changes in expression were similar to those observed in femoral 
arteries, although none of the changes towards an increased expression were significant. 
Nevertheless, the expression profile of ion channels in cultured VSMCs in both vascular beds showed 
a remarkable similarity (Supplemental Figure V). As shown in the figure, Kv1.3 represents the main 
Kv1 mRNA present in both preparations. Other similarities are also apparent in other channel families 
that can deserve a more detail study, as some of them have not been previously reported. One is the 
presence of BKbeta4 as the most abundant accessory subunit of BK channels in cultured cells (as 
opposed to contractile cells, that show a clear predominance of BKbeta1, see figure 1). Another one is 
the dominant expression of Kir2.1 among all the Kir channels in cultured cells, while in contractile cells 
the mRNA expression levels of Kir6.1 and Kir2.2 are about 3 to 5 times higher than those of Kir2.1 
(see figure 1). Finally, proliferation in both preparations led to a down-regulation of L-type Ca2+ 
channels (mainly Cav1.2) so that mRNA encoding for a T-type Ca2+ channel (Cav3.1) becomes 
predominant in cultured VSMCs. 
The effects of Kv channel blockers on proliferation (measured as the % of cells incorporating BrdU) 
were also explored in cultured mesenteric VSMCs (Supplemental figure VIA). In agreement with our 
results with femoral VSMCs, we found that proliferation rate decreased in the presence of Kv1.3 
selective blockers (10 nM PAP-1) being unaffected by blockers of Kv2 channels (50 nM ScTx). 
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Study of the effects of Kv1.3 blockade on proliferation of cultured VSMCs from 
human uterine artery  
In a previous work of our group, we have characterized the changes in the expression and function of 
Kv channels upon phenotypic switch in VSMCs from human uterine arteries7, and we found that Kv3.4 
channels were up-regulated in cultured uterine VSMCs and their blockade reduced proliferation rate. 
However, we also described in that work the up-regulation of Kv1.3 channel protein in proliferating 
VSMCs, so we explored here its possible involvement in uterine VSMCs proliferation. We found that 
proliferation of human uterine VSMCs is significantly reduced after Kv1.3 blockade (figure VIB), 
although the absolute magnitude of the effect is smaller than in cultured femoral VSMCs (compare 
with figure 6D). Altogether, these results suggest that the association between up-regulation of Kv1.3 
channels and proliferation of VSMCs may be present in different species and different vascular beds. 
 
FIGURE LEGENDS 
 
Supplemental Figure I. Changes in the expression of eNos (as endothelium marker) and Cnn1 (as 
smooth muscle marker) genes in femoral arteries treated mechanically (with a pipette tip) or/and 
chemically (by perfusion with 0.1% Triton X-100) to remove endothelial cells. Differences in 
expression were calculated using Gapdh as endogenous control and clean arteries with intact 
endothelium as the calibrator. The changes are represented as log(2−ΔΔCt), where  
ΔΔCt=ΔCtproblem–ΔCtcalibrator 
and 2−ΔΔCt represents the expression fold change. Each bar is the mean of 4-6 data from 2 assays for 
each condition. *p<0.05; ***p<0.001. 
 
Supplemental Figure II. A. Representative figures of the immunocytochemistry with anti-calponin 
antibody in cultured femoral VSMCs and HEK cells (used as negative control). Staining of VSMCs was 
evident even in control media, in the presence of 5% FBS. The lower plots show the quantification of 
Calponin mRNA (Cnn1) by real time PCR in both preparations. Cnn1 mRNA levels were normalized to 
the mRNA levels of a housekeeping gene (Gapdh) and Cnn1 levels in contractile femoral VSMCs 
(tissue) were used as calibrator. We observed a ten-fold decrease in the expression levels of this 
marker of contractile VSMCs in cultured VSMCs, but there was almost no expression in HEK cells 
(mRNA levels decreased by 105). B. Expression of another two smooth-muscle specific contractile 
proteins, smooth muscle alpha actin (SMαA) and SM22, was also explored in cultured femoral VSMCs 
and HEK cells. While SM22 labelling gave a strong signal even in cells cultured in 5% FBS, 
expression of SMαA was weak in these conditions, increasing dramatically after culturing the cells 
during several days in the absence of FBS. The figure show the typical labelling detected before (d0) 
and after 6 days in SF medium (d6). 
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Supplemental Figure III. Changes in the expression pattern of ion channels under proliferation. 
Differences in expression in cultured VSMCs (red bars) and in the endoluminal lesion at different times 
(white-grey-black bars) were calculated using the contractile VSMCs expression levels as calibrator. 
The changes are represented as log(2-ΔΔCt), where  
ΔΔCt=ΔCtproliferative–ΔCtcontractile 
and 2-ΔΔCt represents the expression fold change. Each bar is the mean of 6-10 data from 3-5 assays 
in duplicate for each condition. *p<0.05; **p<0.01; ***p<0.001. Red asterisks indicate p level for 
cultured VSMCs and black asterisk the p value for the anova test of the endoluminal lesion samples. 
 
Supplemental Figure IV. Two way hierarchical agglomerative clustering applied to 59 genes 
(horizontally) and to samples of VSMCs obtained from mesenteric (M1-M4), femoral (F1-F3) and aorta 
(A1-A5) arteries (vertically). The input data was the ΔCt value for each gene in each sample, 
representing the mean of duplicate determinations. Each colour patch in the map represents the gene 
expression level for each gene and sample. The genes expression levels were normalized within each 
sample, with a scale ranging from bright green (lowest) to bright red (highest). Missing values are 
shown as grey patches. The length of the tree branches is proportional to the correlation of the genes 
expression pattern. Some of these clusters of genes with their correlation coefficients are marked with 
the yellow boxes that selected (from top to bottom) the genes that are more abundant in conduit 
arteries (femoral and aorta) than in resistance arteries (mesenteric), the genes more abundant in 
mesenteric and femoral arteries as compared to aorta and the genes more abundant in resistance 
vessels (mesenteric). The blue box selected a group of genes showing lower levels of expression in 
femoral arteries than in the other two vascular beds, that includes the two pore domain channel TWIK 
and Kv1.3 and Kvβ2 subunits. Conversely, the purple box indicates the genes with higher mRNA 
expression in femoral arteries, including Trpm3, Cav3.a and IK1.  
 
Supplemental Figure V. Relative abundance of the ion channel genes studied in cultured VSMCs 
from mesenteric and femoral arteries. Expression levels are normalized with respect to RP18S and 
relative abundance was expressed as 2-ΔCt, where  
ΔCt=Ctchannel-Ct18s 
Each bar is the mean of 4-6 determinations obtained in 2-3 duplicate assays. The colour code has 
been used to identify different gene families.  
 
Supplemental Figure VI. A. Study of the proliferation rate (measured as % of cells incorporating 
BrdU) of cultured mesenteric VSMCs in the absence of FBS (SF, serum-free), or in culture media 
supplemented with 5% SFB alone (control) or in the presence of a Kv1.3 blocker (10 nM PAP-1) or a 
Kv2 blocker (50 nM Stromatoxin).** p<0.01. B. Effect of Kv1.3 channel blockers (10 nM PAP-1 or 10 
nM Margatoxin) on proliferation of cultured human uterine VSMCs. Data are mean ± SEM of 6 
experiments. ** p<0.01. C. Representative images of DAPI staining and BrdU labelling in control and 
10 nM MgTx-treated human uterine cultured VSMCs. 
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